Lifeist Wellness (TSE:LFST) has released an update.
Lifeist Wellness Inc.’s subsidiary Mikra is seeking Canadian approval for CELLF 2.0, a cellular health product designed to enhance energy, focus, and longevity. The successful application for a Natural Product Number would enable Canadian marketing and distribution, capitalizing on positive clinical trials highlighting CELLF 2.0’s cognitive and anti-aging benefits. Lifeist aims to expand its natural, scientifically-backed wellness products to a broader market in 2024.
For further insights into TSE:LFST stock, check out TipRanks’ Stock Analysis page.
